AI-powered therapeutic target discovery

FW Pun, IV Ozerov, A Zhavoronkov - Trends in pharmacological sciences, 2023 - cell.com
Disease modeling and target identification are the most crucial initial steps in drug
discovery, and influence the probability of success at every step of drug development …

Dissecting metastasis using preclinical models and methods

JD Hebert, JW Neal, MM Winslow - Nature Reviews Cancer, 2023 - nature.com
Metastasis has long been understood to lead to the overwhelming majority of cancer-related
deaths. However, our understanding of the metastatic process, and thus our ability to …

MLL3 loss drives metastasis by promoting a hybrid epithelial–mesenchymal transition state

J Cui, C Zhang, JE Lee, BA Bartholdy, D Yang… - Nature cell …, 2023 - nature.com
Phenotypic plasticity associated with the hybrid epithelial–mesenchymal transition (EMT) is
crucial to metastatic seeding and outgrowth. However, the mechanisms governing the hybrid …

Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer

M Wang, X Chen, P Tan, Y Wang, X Pan, T Lin, Y Jiang… - Cancer Cell, 2022 - cell.com
Cisplatin-based chemotherapy remains the primary treatment for unresectable and
metastatic muscle-invasive bladder cancers (MIBCs). However, tumors frequently develop …

The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer

G Gao, S Hausmann, NM Flores, AM Benitez… - Nature …, 2023 - nature.com
The coactivator associated arginine methyltransferase (CARM1) promotes transcription, as
its name implies. It does so by modifying histones and chromatin bound proteins. We …

Nanotechnology-empowered lung cancer therapy: from EMT role in cancer metastasis to application of nanoengineered structures for modulating growth and …

HM Saleem, P Ramaiah, J Gupta, AT Jalil… - Environmental …, 2023 - Elsevier
Lung cancer is one of the leading causes of death in both males and females, and it is the
first causes of cancer-related deaths. Chemotherapy, surgery and radiotherapy are …

Methylation across the central dogma in health and diseases: new therapeutic strategies

R Liu, E Zhao, H Yu, C Yuan, MN Abbas… - Signal Transduction and …, 2023 - nature.com
The proper transfer of genetic information from DNA to RNA to protein is essential for cell-
fate control, development, and health. Methylation of DNA, RNAs, histones, and non-histone …

[HTML][HTML] The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy

Y Yang, M Zhang, Y Wang - Journal of the National Cancer Center, 2022 - Elsevier
Histone modifications are key factors in chromatin packaging, and are responsible for gene
regulation during cell fate determination and development. Abnormal alterations in histone …

Lung cancer organoids: the rough path to personalized medicine

R Rossi, ML De Angelis, E Xhelili, G Sette, A Eramo… - Cancers, 2022 - mdpi.com
Simple Summary Lung cancer is very difficult to cure, especially when it has spread to other
parts of the body. One of the main reasons that delay the identification of effective therapies …

Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities

J Chen, F Na - Frontiers in Bioengineering and Biotechnology, 2022 - frontiersin.org
The prevalency of lung disease has increased worldwide, especially in the aging
population. It is essential to develop novel disease models, that are superior to traditional …